KarXT is great, but GLP is a Tsunami. Neuland’s process patents on Semeglutide and Liraglutide should be watched – these drugs will come out of patent in the coming years. Manufacturing GLPs at scale can easily make Neuland a $10B company.
| Subscribe To Our Free Newsletter |
